Company Overview
American HealthCare Capital is pleased to exclusively introduce AI digital health services business for sale. The company was founded in 2022 by four partners and is headquartered in the Northwest. The company specializes in Digital Health Infrastructure in age technology, as well as oncology (chronic disease care) Digital Health Services. The product incorporates RPM (remote patient monitoring) and EMR integration by using wearable and ambient biosensors with AI-powered data analytics.
Individuals who are 55+ and at heightened risk of infections daily and more so in the next pandemic. There are over 9 million people who are immunocompromised in the USA. Novel cancer treatments like immunotherapy require better at home health and monitoring to detect early compromise. The demand for in-home care requires solutions to securely monitor patients and outbreaks without burden on health systems and with better outcomes.
Biosensors are meticulously chosen to fit senior and immunocompromised patients and continuously monitor key vital signs of the patient. The AI technology tracks changes in the trajectory of vitals and provides early indicators of deterioration in health. This method of monitoring has proven to have 9X improved detection of actionable hypoxia alerts. This is based upon completed multi-site clinical studies during the COVID-19 pandemic.
Company Advantages
The monitoring is device-agnostic, including mass market products like Apple watch, Oura ring and FitBit. Vitalink also has special revenue sharing agreements with two, top-of-its class device manufacturers, particularly suited for senior care and chronic cancer care patients.
The monitoring is also EMR agnostic, with the ability to integrate additional EMRs as needed. Vitalink also offers its own secure, sophisticated, integrated solution, so EMR integration is optional, but not required.
This method is Scalable and Cost effective using secure SaaS solutions, stand-alone or integrated with EMRs, and allows for rapid adoption in cases of infectious disease outbreak or for chronic use. Additionally, the method is billable to insurance using current RPM/RTM codes.
Financial Overview
The AI digital health services business started in 2022 and is starting to see some growth. In their inaugural year, the team was making introductions and presenting their product. Traction was gained in 2023 and with one medical network on board, and they are waiting for a decision from two more. The business development team made significant progress in 2024, with introductions and presentations to new potential clients and market leading EMR integration with access to two million patients annually. The anticipated revenue for the year ending 2025 is a minimum of $300,000.
Growth Opportunities
The opportunities for growth can be achieved with targeted marketing and an increase in Business Development. The company could target large MSA’s with a big network of providers who have over 1,500/2,000 beds a month. They could also continue to utilize the strong network currently in place and industry relationships with doctors who are not part of the program.
Asking Price
Asking price for the business is $1 million.
